Considering increases in mitotic factors such as basic fibroblast growth factor (bFGF) and inflammatory process inducers such as nitric oxide synthase, leukotrienes may promote a cellular deficit from ischemia [43]. This evidence concerns the gene FGF2 and ischemia.